Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Publication date: Available online 10 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, Alexander Oleskin, Marina Boziki, Christos Bakirtzis, Evangelia Kesidou, Nikolaos Grigoriadis, Alexey Boykо (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 11, 2021 Category: Neurology Source Type: research

MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review
Publication date: Available online 9 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Samuele Bonomi, Shan Jin, William J. Culpepper, Mitchell T. Wallin (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 10, 2021 Category: Neurology Source Type: research

Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: potential association between demyelination and tumor necrosis factor inhibitors
Publication date: Available online 10 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Wenjng Luo, Rui Li, Yanyu Chang, Hongda She, Allan G Kermode, Wei Qiu (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 10, 2021 Category: Neurology Source Type: research

B cell therapy and the use of RNA-based COVID-19 vaccines
Publication date: Available online 8 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Anastasia Vishnevetsky, Chris Hawkes, Jeannette Lechner-Scott, Gavin Giovannoni, Michael Levy (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

Underutilization of Contraception in Young Females with Demyelinating Disorders
Publication date: Available online 9 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Jonathan D. Santoro, Brigitte Hurtubise, Justin Del Rosario, Dania Pagarkar, Sarah E. Wiegand, Elaine Su, Nusrat Ahsan (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy
Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

A Pharmacokinetic and Biomarker Study of Delayed-Release Dimethyl Fumarate in Subjects with Secondary Progressive Multiple Sclerosis: Evaluation of Cerebrospinal Fluid Penetration and the Effects on Exploratory Biomarkers
Publication date: Available online 24 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Keith R. Edwards, Aneesh Kamath, Judy Button, Vineetha Kamath, Jason P. Mendoza, Bing Zhu, Tatiana Plavina, Caroline Woodward, Natalia Penner (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
Publication date: Available online 25 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): MengJiao Sun, Ning Liu, QinFang Xie, Xiaoling Li, Jing Sun, Hongxia Wang, ManXia Wang (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Effectiveness of Treatments in Neuromyelitis Optica to Modify the Course of Disease in Adult Patients. Systematic Review of Literature.
Publication date: Available online 25 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mario Velasco, Luis Alfonso Zarco, Mariana Agudelo-Arrieta, Isabel Torres-Camacho, Elkin Garcia-Cifuentes, Oscar Muñoz (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis
Publication date: Available online 28 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ava Hashempour, Javad Moayedi, Zahra Musavi, Farzaneh Ghasabi, Mehrdad Halaji, Zahra Hasanshahi, Mohammad Ali Nazarinia (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy.
Publication date: Available online 28 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

The concurrence of multiple sclerosis and glioblastoma
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Samir Alkabie, Rhaisa Castrodad-Molina, Kent A. Heck, Jacob Mandel, George J. Hutton (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Rate, Burden, and Treatment of Sexual Dysfunction in Multiple Sclerosis: The Case for Exercise Training as a New Treatment Approach
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Dena Sadeghi Bahmani, Robert W Motl (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

“Peppering the Pons”: CLIPPERS or Myelin Oligodendrocyte Glycoprotein Associated Disease?
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ahmed Z. Obeidat, Allison N. Block, Sam I. Hooshmand (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries
Publication date: Available online 3 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Viktoria Papp, Kim D.P. Trones, Melinda Magyari, Nils Koch-Henriksen, Anna Iljicsov, Cecilia Rajda, Helle H. Nielsen, Gabor Lovas, Csilla Rozsa, Bjørn H. Kristiansen, Egon Stenager, Jette L. Frederiksen, Samuel Komoly, Finn Sellebjerg, Thor Petersen, Zsolt Illes (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research